Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by jopatcloon Jul 04, 2024 8:06am
68 Views
Post# 36117721

Hugh MacNaught likes this.

Hugh MacNaught likes this.Interesting for Ventripoint Canada ! Nice  pictures.
We had an amazing experience at last week’s IP for Business Growth conference, hosted by New Ventures BC and Innovate BC at SFU VentureLabs. Founders and experts shared their insight into the impact of IP on valuations in a half-day of learning, discussion, and networking.

INETCO’s CEO and Founder, Bijan Sanii
, participated in a thought-provoking panel discussion on how to monetize IP as your company grows. Panelists shared their knowledge and experience in using IP as a tool for locking in the value of a company and the importance of IP in providing a foundation for innovation, acquiring customers, and attracting partners and investment.

A huge thank you to our co-panelists Barry Jinks
(UBC Electrical and Computer Engineering), Hugh MacNaught (Ventripoint Diagnostics Ltd.), Steph (Pharo) Rose (Rotoliptic Technologies Inc.) and moderator Geoffrey Hansen (Garibaldi Capital Advisors) for sharing your experience and insight, and to all attendees for your active participation and questions.

Special thanks to Hon. Brenda Bailey, Minister of Jobs, Economic Development and Innovation, and Peter Cowan, Innovate BC’s President and CEO for the closing fireside chat with a look ahead for IP in British Columbia.

Lastly, a special thank you to all speakers and moderators for sharing your thoughts and wisdom on navigating IP: Houston Brown, PhD, In House IP; Robert O., Life 360 Innovations; Ling Wong, Fasken; Conor Sheehan, UnitedLex, and Susan Tees, Tees IP.

We’re looking forward to learning and sharing more with all of you in the future!

hashtagintellectual property

<< Previous
Bullboard Posts
Next >>